Ultragenyx Pharmaceutical (RARE) is back in focus after the European Medicines Agency validated its Marketing Authorisation ...
Record global approvals, CRISPR breakthroughs, and expanding clinical and commercial activity are accelerating demand for cell and gene therapy tools and reagents.Dublin, Oct. 08, 2026 (GLOBE NEWSWIRE ...
inews.co.uk on MSN
A cure for blindness is coming
A Nobel-winning therapy that can activate nerves with the flick of a switch is also being turned into treatments for deafness ...
Corey Pavin revealed his wife Lisa's cancer never fully went away and she is now undergoing CAR-T therapy at the Mayo Clinic ...
Researchers report encouraging findings from the first clinical cohort of blind people treated with optogenetic therapy ...
Nuevocor, a clinical-stage biotechnology company pioneering mechanobiology-targeted therapies designed to address the root causes ...
Rocket Pharmaceuticals (RCKT) rose in afternoon trading on Thursday after Goldman Sachs upgraded the gene therapy developer to Neutral from Sell, citing the latest updates on RP-A501, its experimental ...
The 1995 US Open winner announced on Instagram that she had to undergo a cell-based gene therapy as part of treatment. He has ...
Nakai lab receives three NIH grants to develop potential curative treatments for inherited kidney diseases Hiroyuki Nakai, ...
Valentina Ruggeri’s parents were told their little girl was the only person in Australia with an ultra-rare genetic condition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results